I got back on board DNDN last week during the sell off. $5.41 looked like too attractive of a price considering pending news from the company. Today news should move DNDN's story into the broader presses as well as allow analysts to start new coverage, or have current ones issue upgrades.
While I'm not sure which way the FDA review will go, I do believe that this stock will most likely start to ramp up in PPS over the next 3+ months. Could see 8-9 bucks by the New Year IMHO.
Best, Spartex
OT: Dew, fyi I'll be running in Boston marathon this April 17. Should be an exciting event, and something I've been looking forward to doing the past 4 years.
